Jonathan S Wall Selected Research

Jonathan S Wall Research Topics

Disease

28	Amyloidosis 01/2022 - 01/2006
20	Immunoglobulin Light-chain Amyloidosis 09/2021 - 09/2003
20	Amyloid Plaque 01/2021 - 09/2005
6	Neoplasms (Cancer) 01/2019 - 09/2003
5	Inflammation (Inflammations) 01/2021 - 09/2005
5	Multiple Myeloma 06/2018 - 11/2008
4	Proteostasis Deficiencies 06/2018 - 06/2007
3	Infections 01/2019 - 01/2015
3	Rare Diseases (Rare Disease) 01/2017 - 12/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 11/2008
2	Transthyretin-Related Hereditary Amyloidosis 01/2020 - 08/2011
2	Disease Progression 03/2014 - 12/2011
2	Neoplasm Metastasis (Metastasis) 05/2012 - 01/2011
1	Human Influenza (Influenza) 01/2019
1	Monoclonal Gammopathy of Undetermined Significance 06/2018
1	Immunoproliferative Disorders 01/2017
1	Cytomegalovirus Infections (Inclusion Disease) 11/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Cardiomyopathies (Cardiomyopathy) 01/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Rheumatoid Arthritis 01/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Insulin Resistance 08/2012
1	Obesity 08/2012
1	Sclerosis 05/2011
1	Atherosclerosis 05/2011
1	Mucopolysaccharidosis I (Hurler Syndrome) 05/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2008
1	Brain Diseases (Brain Disorder) 06/2007

Drug/Important Bio-Agent (IBA)

34	Amyloid (Amyloid Fibrils)IBA 09/2021 - 09/2003
21	Peptides (Polypeptides)IBA 01/2022 - 06/2007
17	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2003
7	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 08/2011
6	AntibodiesIBA 09/2021 - 02/2007
6	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020 - 11/2010
6	AA amyloidosisIBA 10/2017 - 09/2005
5	Indicators and Reagents (Reagents)IBA 12/2017 - 09/2003
5	Serum Amyloid P-ComponentIBA 03/2016 - 09/2005
4	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2021 - 08/2011
3	EpitopesIBA 09/2021 - 02/2007
3	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021 - 11/2016
3	GlycosaminoglycansIBA 03/2016 - 05/2011
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2015
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2018 - 06/2007
2	peptide p5 plus 14IBA 01/2017 - 04/2015
2	Blood Proteins (Serum Proteins)IBA 01/2015 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 08/2012 - 01/2011
2	Amyloidogenic ProteinsIBA 12/2010 - 06/2007
2	Monoclonal AntibodiesIBA 01/2006 - 12/2003
1	VaccinesIBA 01/2019
1	monoclonal antibody 11-1f4IBA 01/2019
1	AlbuminsIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Iodine-124IBA 01/2017
1	Ganciclovir (Cytovene)FDA LinkGeneric 11/2016
1	Peptide Hydrolases (Proteases)FDA Link 11/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	LigandsIBA 01/2016
1	Proteoglycans (Proteoglycan)IBA 01/2015
1	PalmitatesIBA 08/2012
1	Leucine (L-Leucine)FDA Link 08/2012
1	SirtuinsIBA 08/2012
1	AdiponectinIBA 08/2012
1	Sirtuin 1IBA 08/2012
1	Glucose (Dextrose)FDA LinkGeneric 08/2012
1	ResveratrolIBA 08/2012
1	toceranib phosphateIBA 05/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2012
1	Iduronidase (alpha-L-Iduronidase)IBA 05/2011
1	Claudin-5IBA 05/2011
1	Therapeutic UsesIBA 11/2008
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2008
1	Immunoglobulin lambda-ChainsIBA 11/2008
1	allogenic effect factor (AEF)IBA 06/2007
1	PrionsIBA 06/2007
1	Iodine-123IBA 09/2005

Therapy/Procedure

7	Therapeutics 06/2018 - 05/2011
5	Immunotherapy 12/2017 - 12/2003
1	Precision Medicine 01/2020
1	Transplantation 01/2015
1	CT protocol 01/2015
1	Radiotherapy 01/2013
1	Intravenous Administration 05/2011
1	Euthanasia (Mercy Killing) 09/2008
1	Drug Therapy (Chemotherapy) 12/2003